AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Ranitidine Hydrochloride Equivalent To Ranitidine

40 registrations across 1 African market— 13 active

Markets with Ranitidine Hydrochloride Equivalent To Ranitidine

🇿🇦South Africa
40 registrations
13 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
RANTAC EFFERVESCENT 300🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
RANTAC EFFERVESCENT 150🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ULTAK-75🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
ULTAK 300🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
ULTAK-150🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
RANACID 150 TABLETS🇿🇦South AfricaMedicine Developers International (Pty) LtdsuspendedFeb 2024
RANACID 300 TABLETS🇿🇦South AfricaMedicine Developers International (Pty) LtdsuspendedFeb 2024
WATSON RANITIDINE 150🇿🇦South AfricaARROW PHARMA SOUTH AFRICA (PTY) LTDsuspendedJan 2024
WATSON RANITIDINE 300🇿🇦South AfricaARROW PHARMA SOUTH AFRICA (PTY) LTDsuspendedJan 2024
SIMAYLA RANITIDINE 300🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdsuspendedDec 2023
SIMAYLA RANITIDINE 75🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdsuspendedDec 2023
SIMAYLA RANITIDINE 150🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdsuspendedDec 2023
APEX-RANITIDINE 150 mg🇿🇦South AfricaCamox Pharmaceuticals (Pty) LtdsuspendedApr 2023
CAMOX-RANITIDINE 150 mg🇿🇦South AfricaCamox Pharmaceuticals (Pty) LtdsuspendedApr 2023
APEX-RANITIDINE 300 mg🇿🇦South AfricaCamox Pharmaceuticals (Pty) LtdsuspendedApr 2023
CAMOX-RANITIDINE 300 mg🇿🇦South AfricaCamox Pharmaceuticals (Pty) LtdsuspendedApr 2023
AUSTAC-75🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdsuspendedApr 2023
AUSTELL RANITIDINE 75 mg🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdsuspendedApr 2023
AUSTAC-150🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdsuspendedApr 2023
AUSTAC-300🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdsuspendedApr 2023
DAZAN EFFERVESCENT 150🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedMar 2023
GULF RANITIDINE 150🇿🇦South AfricaGulf Drug Company (Pty) LtdsuspendedDec 2022
GULF RANITIDINE 300🇿🇦South AfricaGulf Drug Company (Pty) LtdsuspendedDec 2022
RANIGULF 75🇿🇦South AfricaGulf Drug Company (Pty) LtdsuspendedDec 2022
R-LOC INJECTION 50 mg/2 ml🇿🇦South AfricaZydus Healthcare (Pty) LtdsuspendedAug 2022
PHARMACARE-RANITIDINE 150 mg🇿🇦South AfricaGAREC (PTY) LTDsuspendedJun 2022
PHARMACARE-RANITIDINE 300 mg🇿🇦South AfricaGAREC (PTY) LTDsuspendedJun 2022
RANIT 300 mg🇿🇦South AfricaCospharm Investments (Pty) LtdactiveJan 1900
TRIO-RANITIDINE 300🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
RANITIDINE INJECTION PHARMA-Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
RANITIDINE BIOTECH 300🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
RANITIDINE BIOTECH 150🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
RANITIDINE 150 PHARMA Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
RANIT🇿🇦South AfricaCospharm Investments (Pty) LtdactiveJan 1900
RANIT 150 mg🇿🇦South AfricaCospharm Investments (Pty) LtdactiveJan 1900
RAMETINE 150🇿🇦South AfricaACINO PHARMA (PTY) LTDactiveJan 1900
RANITIDINE 300 PHARMA Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
GASTRO-FIZZ 75🇿🇦South AfricaALCHEMY PHARMACEUTICALS CCactiveJan 1900
DAZAN EFFERVESCENT 300🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
RAMETINE 300🇿🇦South AfricaACINO PHARMA (PTY) LTDactiveJan 1900

Ranitidine Hydrochloride Equivalent To Ranitidine in Africa — Regulatory Overview

Ranitidine Hydrochloride Equivalent To Ranitidine is registered across 1 African markets with 40 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 40 registrations, 13 (33%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.